[PSTX] QoQ Quarter Result on 30-Jun-2022 [#Q2]

Stock
[PSTX] Poseida Therapeutics, Inc.
Announcement Date
11-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- 24.73%
YoY- 2.58%
Quarter Report
PSTX's Result
PSTX's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 10,343 9,921 116,306 2,700 1,435 31 0 -
PBT -38,847 -33,026 70,661 -43,036 -58,057 1 -42,424 -5.70%
Tax 1,359 292 252 1,491 1,096 -17,602 840 37.85%
NP -40,206 -33,318 70,409 -44,527 -59,153 1 -42,424 -3.51%
Tax Rate - - -0.36% - - 1,198,216.25% - -
Total Cost 50,549 43,239 45,897 47,227 60,588 30 42,424 12.40%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin -388.73 -335.85 60.54 -1,649.15 -4,122.16 4.70 0.00 -
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS -0.47 -0.39 0.92 -0.71 -0.95 0.02 -0.68 -21.84%
EPS Diluted -0.47 -0.39 0.92 -0.71 -0.95 0.02 -0.68 -21.84%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.